Home
Search results “Astrazeneca asthma medication dangers”
Symbicort Side Effects - Dangers with Better Solutions
 
07:41
Click on the link below for a free video guide to shopping for dietary supplements. http://utahtexans.com/ In this video I'm going to share some of the major side effects of the drug symbicort and I'm going to share a few better options. Breathing is important right? Symicort does help someone breath by reducing inflammation in the airways. It's commonly prescribed to people with asthma or lung disease. If you don't have insurance this inhaler is going to cost around $300, which is expensive. It lasts about 30 days if you take 2 puffs a day. The main ingredient in this drug is Formoterol. Researchers from Cornell and Stanford universities have looked at 19 trials with over 33 thousand patients and have concluded that the ingredient in this drug called Foroterol may be causing 4 out of 5 U.S. Asthma related deaths per year and should be taken off the market. You might be wondering how does this ingredient kill. The answer is according to the researchers is that the medication relieves asthma symptoms, however it promotes inflammation without warning. Almost like they relieve the symptoms for the short term, but make them worse overall. I'll share just 1 study and that is researchers found that 53 of 3,083 patients inhaling this ingredient were hospitalized for an asthma attack, compared with 12 of 2,008 patients who received a placebo. Let's talk about some of the most common side effects and that would be headache, throat irritation, nausea, vomiting, stomach upset, diarrhea, back pain, stuffy nose, muscle or joint pain, or changes in your voice. Of course there are many other side effects that you could experience depending on how your body reacts to the drug. At this point you might be wondering if there are better options. I would highly encourage you to look at bee pollen for allergies. According to the “Journal of Allergy” 78% of asthma patients averaged a 75% improvement after taking bee pollen. Another great idea that is often overlooked is vitamin D, which you can get in a multivitamin. In the September issue of the “Annals of Allergy, Asthma & Immunology” researchers reviewed nearly 60 years' worth of literature on vitamin D with asthma. They found that a vitamin D deficiency is linked to increased airway reactivity, lower lung functions, and worse asthma control. To learn more ideas click on the link below. http://utahtexans.com/
Views: 9873 kwhitsitt1
Daily briefing: us approves astrazeneca severe asthma drug
 
02:44
Thanks for watching❤! SUBSCRIBE to receive more videos for free. Daily briefing: us approves astrazeneca severe asthma drug Published 1700 EST, 15 November 2017 Updated 1700 EST, 15 November 2017 AstraZeneca has won US approval for a treatment for severe asthmaASTHMA APPROVAL Drugmaker AstraZeneca has won US approval for a treatment for severe asthma. Benralizumab will be marketed under the name Fasenra. JAPAN GROWTH The Japanese economy grew at an annual rate of 1.4 per cent in the third quarter – notching up its longest streak of expansion – 21 months – since 2001.VAT PLEA Firms with less than £85,000 of sales are not charged VAT but the Federation of Small Businesses has warned they would be hammered if the threshold comes down as Chancellor Philip Hammond attempts to raise extra cash. CARD JOY Greetings card firm Card Factory has cheered a solid third quarter, saying growth has continued, with sales up by 6.7 per cent in the nine months of its year so far. VENEZUELA WRITEOFF Russia has thrown crisisridden socialist nation Venezuela a lifeline by saying it can pay back £2.4billion of debt more slowly, am...
Views: 464 Hot News
Biologic Treatments For Asthma: What You Need To Know
 
02:01
Biologics are a new type of asthma medication used to help people living with Severe Asthma gain long-term control of their asthma symptoms. This short video provided by Asthma Canada explains what biologics are, and will help you to decide if you should ask your doctor about them as a treatment option. *Please note that newer biologics have different dosing schedules and may be taken less frequently.
Views: 375 AsthmaCanada
How To Use Your Turbuhaler
 
01:04
A quick guide on how to use a turbuhaler for medications like Symbicort
Views: 584157 George Forgan-Smith
New Drug Found to Control Severe Asthma
 
00:38
Two trials show a new injectable drug can reduce outbursts in patients with severe asthma that is not controlled by steroid inhalers alone. The new drug, benralizumab, works by targeting white blood cells called eosinophils, that are usually present in large numbers, in patients that have been linked to severe asthma. According to researchers, if the U.S. Food and Drug Administration approves of the new drug, it would offer new options to control asthma. http://www.upi.com/Health_News/2016/09/07/New-injectable-drug-fights-hard-to-control-asthma/5461473258750/ http://www.wochit.com This video was produced by YT Wochit News using http://wochit.com
Views: 886 Wochit News
New Asthma Drug Stops Attacks
 
01:52
Imagine struggling to fill your lungs with air and with each breath, feeling like you’re suffocating. That’s what happens to more than 18-million Americans who suffer from asthma.
Views: 1826 NewsChannel 5
how to use symbicort turbuhaler
 
01:28
two important points about symbicort 1- The sound of the hygroscopic agent does not represent the presence of medications 2- Important to close also at the end tightly to avoid humidity to reach the dry powder medication
Views: 274129 Medicopedia
BIOLOGICS FOR SEVERE ASTHMA
 
01:40
A new class of medicines are helping people with severe asthma breathe easier
Views: 238 Ivanhoe Web
Drugs giant Pfizer drops AstraZeneca bid - economy
 
00:36
US drugmaker Pfizer has abandoned its multi-billion takeover bid for UK pharmaceutical firm AstraZeneca. The US company said it would not pursue the takeover past a bid deadline on Monday. AstraZeneca rejected a final offer earlier this month saying the proposal undervalued the company and its "attractive prospects". Under UK takeover rules Pfizer must wait six months if it is to make a fresh bid unless invited to do so by AstraZeneca. ... READ MORE : http://www.euronews.com/2014/05/26/drugs-giant-pfizer-drops-astrazeneca-bid What is in the news today? Click to watch: http://eurone.ws/1kb2gOl euronews: the most watched news channel in Europe Subscribe! http://eurone.ws/10ZCK4a euronews is available in 14 languages: http://bit.ly/1qPwqgE In English: Website: http://www.euronews.com/news Facebook: http://www.facebook.com/euronews Twitter: http://twitter.com/euronews Google+: http://google.com/+euronews VKontakte: http://vk.com/en.euronews
Symbicort Drug for Bronchospasm: Side Effects, Dosage. & Usage
 
01:51
https://www.findatopdoc.com/Medical-Library/Drugs-and-Supplements/Symbicort - Budesonide and Formoterol, also known and sold under the trade name of Symbicort, is a product which includes a combination of two medications, Budesonide and Formoterol. Visit www.FindaTopDoc.com today to learn more about Symbicort Drug. Also follow us on Social Media: Twitter https://twitter.com/findatopdoc Pinterest https://www.pinterest.com/findatopdoc/ Facebook https://www.facebook.com/FindaTopDoc Linkedin https://www.linkedin.com/company/find-a-top-doc Google+ https://plus.google.com/u/0/103515152849522259645/posts
Views: 1221 FindaTopDoc Media
Symbicort Medication Information (dosing, side effects, patient counseling)
 
02:37
Your medication Symbicort Budesonide and formoterol is also known as the brand name: Symbicort. It is most commonly used to treat asthma in patients over the age of 12 but can also be used to treat asthma in children. No matter how old you are, depending on the severity of your asthma, Symbicort is taken two inhalations twice daily with a maximum of four inhalations per day. It comes in inhaler form and is taken by pressing inhaler to release medicine into mouth and then swallowing. Some common side effects of Symbicort are headaches and upper respiratory tract infection. Some less common side effects are dizziness, abdominal distress, vomiting, influenza, back pain, bronchitis, and nasal congestion. Symbicort is not a rescue inhaler, and does not replace fast-acting inhalers to treat acute symptoms. Do not take Symbicort if: • You need acute bronchodilation in COPD While taking Symbicort, it is important to remember to tell your doctor or pharmacist if you experience any of the following: • Signs of an infection • Signs of high blood sugar (confusion, fatigue, increased thirst, increased hunger, flushing, fast breathing, etc.) • Signs of low potassium (muscle pain or weakness, muscle cramps or an abnormal heartbeat) • Signs of adrenal gland problems (severe nausea, vomiting, severe dizziness, passing out, muscle weakness, etc.) • Signs of lung problems • Signs of allergic reaction (wheezing, chest tightness, fever, itching, bad cough, blue skin color, seizures, etc.) Symbicort has a US Black Box Warning stating that it can increase the risk of asthma-related death.
HOW TO USE A TURBUHALER
 
05:09
This video discusses the proper use of the Turbuhaler. The Turbuhaler is a type of "dry powder" delivery device. The fine powder is inhaled deep into your lungs.
Mario Castro "Severe Asthma Data from SARP"
 
01:06:04
Dr. Mario Castro (Washington University School of Medicine) presents findings from the Severe Asthma Research Program (SARP), providing insights into severe asthma disease phenotypes and approaches for targeted therapy. Dr. Castro highlights the use of imaging technologies to better understand the lung changes that occur in severe asthma. His findings identify subgroups of patients with specific changes in the lung. The hope is that identification of these subgroups will inform the use of targeted therapies. Dr. Castro also presents data on the effects of dupilumab treatment. Dupilumab is a monoclonal antibody that targets IL-4 receptor alpha (anti-IL-4R). Recent clinical trials published in the New England Journal of Medicine showed that dupilumab treatment improves patient outcomes. This webinar was hosted by the NHMRC Centre of Excellence in Severe Asthma on 19 June 2018. Dr. Castro's travel was supported by funding from AstraZeneca.
Views: 46 SevereAsthmaCRE
New severe asthma treatment 'stopping attacks'
 
05:25
New severe asthma treatment 'stopping attacks': . Thanks for watching, subscribe for more videos: https://www.youtube.com/channel/UCbenv2Jj1liIpl20zSce22g?sub_confirmation=1 A new treatment has been launched in Australia to help adults and teenagers with severe asthma manage their poorly-controlled symptoms.One in nine Australians have asthma and up to 10 percent of patients are living with severe disease.The injection, called Fasenra (benralizumab), is given to sufferers whose inflammation in their airways is triggered by a high number of white blood cells called eosinophils.The antibody is the third in a class of new biological agents to be registered in Australia for severe asthma.It is the "biggest development in asthma treatment for decades".A new injection might offer asthma sufferers new hope.Respiratory physician Dr Gregory Katsoulotos says the medicines are the biggest development in asthma treatment in decades."Previously, people lived in fear of another attack, going to hospital, of not being well," he said."They're now travelling the world."Related ArticlesQueensland hospital workers are being attacked on the job Landmark clinic could 'save lives' through pregnancy-heart disease linkPomegranate recall: Disability worker who died amid recall was about to retireThe new add-on injectable therapy is given every two months, after starting out on monthly jabs."You are choosing these populations who are miserable, who are suffering on steroids, and more than half them are responding in terms of significant improvement of their symptoms," Dr Katsoulotos said."Reduction of their prednisone dose or even, in cases, stopping their prednisone completely. Stopping attacks, stopping presentations to hospital."The most common side-effects include headache, sore throat and a high temperature.Unlike other biological agents Nucala (mepolizumab) and Xolair (omalizumab), Fasenra is not included on the Pharmaceutical Benefits Scheme, although a submission has been made.The injection, Fasenra, is given to sufferers whose inflammation in their airways is triggered by a high number of eosinophils white blood cells.Dr Katsoulotos says a special pharmaceutical program allows the medicine to be available free of charge for up to 12 months.The National Asthma Council welcomes the new treatment option."The day-to-day burden of living with severe asthma can be considerable, including living with side-effects from frequent corticosteroid use," council CEO Siobhan Brophy said. "Novel treatment options provide hope for improving the lives of those affected."Asthma Australia says it's important for people with asthma to recognise when their symptoms aren't getting any better."When left untreated, severe asthma can heavily impact a person's quality of life," Asthma Austrlaia CEO Michele Goldman said.Severe asthma patient Barbara, aged 77, says she can't walk more than 10 metres without struggling to breathe."Even my puffers do not work at the time," she said."My husband has to hang the clothes on the line now because just reaching up, by the time I do that, I can't breathe."People with asthma can find more information on the condition here. #severe, #asthma, #treatment, #stopping, #attacks
Views: 516 Andido caywus
AstraZeneca Heart Disease Drug Gets FDA Approval
 
01:01
AstraZeneca received a much-needed boost when its blood-thinning drug, Brilinta, a potential blockbuster, was approved by the US health regulator for wider use. The Food and Drug Administration approved Brilinta tablets for longer-term use in patients with a history of heart attack. The new 60 mg dose can be taken twice a day along with aspirin beyond a year after a heart attack. Until now, the blood thinner could only be prescribed for one year after a heart attack, as a 90 mg dose. Brilinta is one of the big earners AstraZeneca is counting on to offset falling sales from older bestsellers as they come off patent, such as Nexium and Crestor. http://www.theguardian.com/business/2015/sep/04/astrazeneca-heart-disease-drug-brilinta-gets-fda-approval-at-60mg http://www.wochit.com This video was produced by Wochit using http://wochit.com
Views: 532 Wochit News
Severe asthma: a major unmet need
 
13:22
Severe asthma is often misdiagnosed in both adults and children. Misdiagnosis is a missed opportunity to treat the condition effectively, with great consequences to the patient. Recent developments in phenotyping have provided us with the tools to improve diagnosis and treatment of severe asthma. In the latest instalment of ERS Vision, Professors Guy Brusselle, Andrew Bush and Sally Wenzel explore the issues, recent advances and gaps as we move towards more effective diagnosis and treatment of the condition.
How to use Metered Dose Inhaler (MDI)
 
02:18
Watch moreinhaler videosonhttp://www.use-inhalers.com/ This video helps you learn how to use metered dose inhaler like ProAir, Ventolin and other MDI inhalers. Proper use of inhaler is very important for better medicine outcomes. Missing out on a step may lead to inefficient dosage delivery which inadvertently affects your health. In case of a Metered Dose Inhaler (MDI) like ProAir and Ventolin, getting the actuation and inhaling timing right is very important for getting the right dose. The video is precisely timed so that you can practice taking your mdi inhaler whenever you want to take a dose. At http://www.use-inhalers.com/ we provide inhaler instructions for all major asthma inhalers in a fun and interactive way. We have tools that teach you correct breathing technique for your inhaler, help you practice inhaler technique and then test your inhaler technique for better retention. Above all inhaler instructions are available in major languages like English, Spanish, Portuguese, French and many others. We offer other inhaler training: • MDI with Spacer • Diskus • Handihaler • Respimat • Pressair • Twisthaler • Flexhaler • Autohaler • Aerolizer • Neohaler Want inhaler instructions on the go? Download our iOS apps "How to Use Inhalers" fromhttps://itunes.apple.com/app/id581502355and never forget a step. Need a reminder to use an inhaler? Download your inhaler buddy "Assist Me with Inhalers" from the iOS app store now https://itunes.apple.com/us/app/assist-me-with-inhalers/id590417707?mt=8
Views: 891151 UseInhalers Correctly
WEBINAR – Difficult-to-treat and severe asthma: changing the paradigm
 
58:15
A significant group of people with asthma still have uncontrolled asthma and experience poor outcomes despite high-dose standard therapy. However, recent advances offer hope for improving these outcomes. This webinar by NPS MedicineWise presents a multidisciplinary discussion on new therapies, and how to identify and manage difficult-to-treat and severe asthma. CPD accreditation is available by viewing this webinar on the NPS MedicineWise e-learning site https://learn.nps.org.au/course/view.php?id=543 To download presentation slides, visit https://www.nps.org.au/webinar/asthma ---------------------- This program is joint-funded by AstraZeneca Pty Ltd and Novartis Pharmaceuticals Australia Pty Ltd and managed by VentureWise, a wholly owned commercial subsidiary of NPS MedicineWise. The content has been designed, developed and delivered by NPS MedicineWise with complete independence and editorial control, based on best practice guidelines.
Views: 736 NPS MedicineWise
Second Sunday Bryan Health Report: Severe Asthma Treatment
 
02:21
In this month's edition of Second Sunday, Channel 8 Eyewitness News profiles a new procedure at Bryan Health that is helping patients deal with severe Asthma.
Views: 130 Bryan Health
How to use a metered dose asthma inhaler with a spacer or valved holding chamber.
 
01:19
Watch this American Lung Association video to learn the correct way to use your metered dose (MDI) asthma inhaler. To learn more about asthma, asthma medicines and the American Lung Association visit www.lung.org/asthma, or call 1-800-586-4872.
AstraZeneca drug flops in trial for severe lung disease
 
00:59
AstraZeneca drug flops in trial for severe lung disease One of AstraZeneca’s newest respiratory drugs has suffered a setback after it failed to help people with a type of breathing disorder. Fasenra, AstraZeneca’s first biological respiratory medication, f...
Views: 103 iconnews
FDA approves AstraZeneca's asthma drug
 
00:51
FDA approves AstraZeneca's asthma drug (Audio-Video version for people with limited hearing or vision) The full version of the news is available on http://newsgra.com/english/health/56529-fda-approves-astrazeneca-s-asthma-drug/
Clinical Trials for Asthma & COPD
 
01:40
Clinical trials are research studies that try to find better ways to prevent, screen for, diagnose or treat a disease. These critical studies answer specific questions about new interventions—which can be new vaccines, drugs and devices—and measure their effectiveness and safety for patients. Learn more at Lung.org/acrc.
“Not the end of the road” for Synairgen’s asthma treatment
 
04:48
Synairgen plc (LON:SNG) chief executive Richard Marsden tells Proactive Investors that it’s “not the end of the road” for its asthma treatment after AstraZeneca (LON:AZN) announced it would review how to proceed with the phase IIa trial of the drug. AstraZeneca decided to stop the trial as fewer severe cases were found amongst patients than researchers had expected. “It’s not the end of the road for the drug at all,” Marsden says. The pharma giant will analyse the data generated so far in the trial at the start of next year, and Marsden thinks this could be a good thing. “AstraZeneca [is] going to look at the data in the first quarter of next year, which is probably earlier than we had initially expected.” “If anything, this is all happening earlier in the year than we had anticipated, so this could be good news.”
Non-Drug Treatment for Severe Asthma (Bronchial Thermoplasty) | El Camino Hospital
 
03:52
Approved by the FDA in 2010, Bronchial Thermoplasty is a minimally invasive bronchoscopic procedure that uses a bronchoscope to deliver thermal energy to reduce excessive smooth muscle in the airway and increase airflow. Studies show great results for patients with severe asthma: 32% fewer severe asthma attacks 73% reduction in hospitalizations for respiratory symptoms 84% fewer asthma-related emergency room visits Watch to learn more about this amazing non-drug treatment for severe asthma from Dr. Ganesh Krishna, an interventional pulmonologist and expert in BT treatment.
Views: 1921 El Camino Hospital
Biopharmaceutical Firm AstraZeneca Standardizes on DocuSign for DTM
 
01:25
The DocuSign Global Trust Network empowers biopharmaceutical companies like AstraZeneca to simplify clinical operations, decrease development costs, and reduce risk in security and compliance to bring treatments to market sooner and more efficiently. 14 of the top 15 global pharmaceutical companies and 9 of the top 10 Contract Research Organizations (CROs) have standardized on DocuSign for Digital Transaction Management (DTM).
Views: 3011 DocuSign
Fasenra Commercial (2018)
 
01:01
#LXX = 70 About Benralizumab: Its used to control and prevent symptoms (such as wheezing and shortness of breath) caused by asthma. Controlling symptoms of asthma helps you maintain your normal activities and decreases time lost from work or school. I DO NOT OWN THIS. ALL RIGHTS TO AstraZeneca.
Views: 660 C. B. MCMXCIX
Expert Insights: COPD @ ERS 2015 with Prof Singh
 
03:31
Professor David Singh speaks to us about COPD Patients and the importance of reducing the risk of exacerbations, direct from ERS 2015 in Amsterdam.
Views: 1303 Boehringer Ingelheim
AstraZeneca to develop new drugs to beat chronic diseases
 
02:10
AstraZeneca to develop new drugs to beat chronic diseases Pharmaceutical giant AstraZeneca has announced a research programme to develop a new generation of medicines to treat the genetic causes of many debilitating diseases, such as diabetes, heart disease and many cancers. Since 2000 there were high hopes for the human genome project after the discovery of gene decoding, but 15 years on there has not been much progress. The company has joined forces with the Wellcome Trust Sanger Institute to develop new drugs using an emerging technique called Crispr to "snip out" specific disease genes in order to discover drugs.
Views: 109 WorldNewsChannel
What Happens If You Overdose On Symbicort?
 
00:47
If you are using your inhaler for the first time, need to prime it. Symbicort accidental overdose side effects patientsville. Symbicort (budesonide and formoterol fumarate dihydrate) patient symbicort rxlist drug images side effects. Male, 46 errors can happen in the hospital, at doctor's office, pharmacy, or home. What happens if i overdose symbicort turbuhaler? Contact call your doctor for preventive treatment you are exposed to chicken pox or measles view accidental side effect risks. What happens if i miss a dose (symbicort)? Emedicinehealth. This generally occurs within the first year of treatment. Symbicort turbuhaler 200 6 mydr. Gradual overdose of the symbicort how dangerous is this and can i 80 4. Googleusercontent search. If symbicort therapy has to be withdrawn due overdose of the formoterol before you contact this company often several companies will market medicines find patient medical information for inhalation on webmd including if an asthma attack occurs, use your quick relief inhaler (such as albuterol, also 15 nov 2016 do know can that [albuterol] inhaler? But what happens when child is having early or their it's important don't miss a dose take more doses than prescribed. Symbicort inhaler uses, dosage & side effects drugs. Symbicort turbohaler 400 12, inhalation powder. Symbicort (budesonide and formoterol fumarate dihydrate) patient symbicort side effects, uses, dosage, overdose, pregnancy overdose asthma emedtv. Symbicort side effects, dosage, interactions drugs. If symbicort turbuhaler this combination product contains two medications if you are not sure what to do after missing a dose, contact your doctor or use pregnant breast feeding pharmacist can tell taking any of these medicinesuse only the number inhalations has prescribed 29 jun 2017 turbohaler 200 micrograms 6 inhalation, inhalation powderif oropharyngeal thrush occurs, patients should also rinse their mouth an overdose formoterol would likely lead effects that typical for 2 before company often several companies will 400 12 powder. Symbicort turbuhaler uses, side effects, interactions symbicort medsafe. Symbicort turbuhaler overdose, warnings, precautions, missdose. Symbicort turbohaler 200 6 inhalation powder summary of emc. Summary of symbicort inhalation uses, side effects, interactions, pictures can you overdose on albuterol? My allergy friend myallergyfriendsymbicort (budesonide product monograph astrazeneca canada. If you take too much (overdose) these are less likely to happen if rinse your mouth out after every time use usual 5 jul 2009 symbicort properly, and brush while side effects from can happen, they generally rare before start using it each get a refill. What happens if i overdose (symbicort)? Overdose can cause redness around your nose, runny trouble breathing, nervousness, muscle cramps, dry mouth, nausea, vomiting, sleep problems (insomnia), tremors, chest pain, fast or pounding heartbeats, fainting, and seizure (convulsions) 13 jul 2017 symb
Views: 851 Another Question
Rapihaler®
 
02:09
Executive Interview - Adherium
 
10:08
Adherium (ADR.ASX) is an ASX-listed digital health company developing technologies that address suboptimal medication use and remote patient management in chronic diseases. Adherium’s market-leading Smartinhaler platform has been independently proven to improve adherence to inhaled medications and improve health outcomes in chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD). With an existing 10-year commercial product development and supply agreement with AstraZeneca (AZN) and strong relationships with other global pharmaceutical and medical technology companies and key opinion leaders (KOLs) through sales into the clinical trial sector, Adherium is positioned for strong revenue growth. The company listed on the ASX in August 2015, raising A$35m at A$0.50/share, including a US$3m investment by AZN. In this interview, CEO Garth Sutherland provides an introduction to Adherium and the Smartinhaler technology platform. He discusses the strategic importance of the global supply agreement with AstraZeneca and highlights some key milestones to look out for over the next 12-24 months.
Views: 398 Edison
Asthma, Allergies and the Flu: AANMA Tips
 
05:10
AANMA teamed up with AstraZeneca to provide tips for parents of children with asthma, allergies and related conditions to avoid getting the flu.
Views: 1196 breatherville
Symbicort Meter Accuracy
 
01:57
This video brings some important information to the consumer concerning the meter or dial on the top of a Symbicort Inhaler. This video, in no way, should replace the counsel between you and your doctor. Always follow your doctors advice when taking your medication.
Views: 5075 brianmcdrummer
AstraZeneca Announces First Direct-To-Patient Program Offering ARIMIDEX
 
00:57
AstraZeneca (NYSE:AZN) announced its first-ever direct-to-patient program offering patients with a valid prescription for ARIMIDEX or anastrozole the opportunity to have the brand ARIMIDEX delivered directly to their home by Express Scripts (NASDAQ:ESRX) for $40 per month, including shipping. Steve Davis, Executive Director, Foundation Brands, AstraZeneca said, "ARIMIDEX Direct marks a first for AstraZeneca. We believe it is also the first time eligible patients have a nationwide direct-to-patient option. The program offers the brand ARIMIDEX at the low cost of $40 per month via home delivery. It is an important new way for AstraZeneca to help meet U.S. customer needs." AstraZeneca (NYSE:AZN) has potential upside of 12.6% based on a current price of $45.06 and an average consensus analyst price target of $50.74.
Views: 202 FinancialNewsOnline
Symbicort-Robbie
 
00:59
Views: 82 31beccalynn
Britain's AstraZeneca Rejects 'final' Pfizer Bid
 
01:01
British drug maker AstraZeneca rejected Monday what its New York-based rival Pfizer called over the weekend its "final" takeover offer. In a statement, AstraZeneca's board cited the "uncertainty and risks" for shareholders as a reason for the rejection, which came just hours after the maker of the erectile-dysfunction drug Viagra had upped the value of its bid to about $93 a share in a deal that would have led to the world's largest drugs company. Pfizer's latest bid that came Sunday night valued AstraZeneca at around $116 billion. It said the new offer would be its final one. http://rssfeeds.usatoday.com/~r/UsatodaycomMoney-TopStories/~3/owG97l7VyU8/ http://www.wochit.com
Views: 22 Wochit Business
ASTHMA and Turbuhaler
 
00:42
ASTHMA and Turbuhaler
Views: 480 TurbuhalerNL
Your Guide to Understanding and Treating COPD - Chapter 2 - COPD and It's Effects
 
05:05
Riverside Healthcare and AstraZeneca present Your Guide to Understanding and Treating COPD This educational tool is designed to help patients and caretakers learn more about COPD and ways that may help manage, control or improve symptoms associated with COPD. As a patient, it’s important that you play an active role in the treatment of your COPD, and this video is designed to help you empower yourself with knowledge. This video includes information on the following: • COPD and Its Effects • Diagnosis and Treatment Options for COPD • Healthy Living Tips • Helpful Web Resources Although this video is designed to provide you with information for understanding COPD and some treatment options, you may still have questions. Bring all of your questions to your next office visit for greater and more detailed insight from your care team. This video is not designed to solely treat or manage COPD and its symptoms and should not be relied upon as medical advice. Rather, it is a tool used to complement care plans for patients who have been diagnosed with COPD.
Global COPD and Asthma Devices Market - Industry Analysis 2015-2019
 
00:57
Link to Report: http://bit.ly/1PODXYv Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles. The rising availability of portable drug delivery devices is a significant factor that is responsible for this market’s modest growth rate of nearly 4% by 2019.
Views: 29 Technavio
AstraZeneca Prof MOK TONY
 
00:55
Graphic design and After effects animation I did for Inhouse Interactive.
Views: 56 Tonton Francky
Diagnosing Asthma: A Practical Approach - Dr Hilary Pinnock
 
35:32
Dr Hilary Pinnock discusses practical approaches to diagnosing asthma at SARA's 'Treating the Breathless Patient' training - 8th Sept 2015, IET Teacher Building, Glasgow.
How to Use the Pulmicort Flexhaler - Demonstration
 
01:08
The flexhaler is a dry powder inhaler that delivers steroid medicine, which is used to prevent asthma and its symptoms. Watch how to properly use the pulmicort flexhaler for asthma relief. This video is an excerpt from the DVD Living With Asthma: A Guide to Controlling Your Asthma, produced by St. Louis Children's Hospital. To learn more about childhood asthma, visit http://www.stlouischildrens.org/diseases-conditions/asthma. Learn more about St. Louis Children’s Hospital – Find a Physician, Get Directions, Request an Appointment, See current ER Wait Times http://www.stlouischildrens.org Want to hear more from St. Louis Children’s Hospital? Subscribe to the St Louis Children’s Hospital YouTube Channel: https://www.youtube.com/user/ChildrensHospitalStl Like us on Facebook: https://www.facebook.com/stlchildrens Follow us on Twitter: https://twitter.com/STLChildrens Visit Children’s MomDocs (a blog by mom physicians at St Louis Children’s Hospital and Washington University School of Medicine): http://childrensmd.org. Learn More About Donating on YouTube: https://support.google.com/youtube/?p=donate_FAQ
World News Today - AstraZeneca Wins US Approval for Lymphoma Drug
 
02:19
World News Today - AstraZeneca Wins US Approval for Lymphoma Drug Hello and Welcome channel World News Today! Subscribe Channel World News Today: https://goo.gl/zsVy1s World News Today is a YouTube channel that talks about the: social, political, cultural and artistic issues of water throughout the world: Fine, English, French, .... Channels World News Today always updated the world's hot News for everyone. Don't forget Like, Comment and Share the videos World News Today for your Family and Friends. World News Today For All! Music in video of channel World News Today is Library YouTube. Subscribe channel World News Today to see new videos everyday!
Views: 12 World News Today
Bambuterol
 
09:21
Bambuterol Bambuterol INN is a long-acting β adrenoceptor agonist LABA used in the treatment of asthma; it also is a prodrug of terbutaline Commercially, the AstraZeneca pharmaceutical company produces and markets bambuterol as Bambec and Oxeol1 It is not available in the US Contents 1 Indications 11 Contraindications 2 Adverse effects 3 Interactions 4 References Indications As other LABAs, bambuterol is used in the long-term management of persistent asthma1 It should not be used as a rescue medication for short-term relief of asthma symptoms Contraindications Bambuterol is contraindicated in pregnancy and in people with seriously impaired liver function It can be used by people with renal impairment, but dose adjustments are necessary1 Adverse effects The adverse effect profile of bambuterol is similar to that of salbutamol, and may include fatigue, nausea, palpitations, headache, dizziness and tremor1 Interactions Concomitant administration of bambuterol with corticosteroids, diuretics, and xanthine derivatives such as theophylline increases the risk of hypokalemia decrease Bambuterol Click for more; https://www.turkaramamotoru.com/en/bambuterol-23782.html There are excerpts from wikipedia on this article and video
Views: 37 Search Engine
Symbicort
 
00:33
Bus
Views: 8637 interconnector
Asthma Canada Patient Education - Influenza and Asthma
 
01:24:56
Watch a recording of the 1st National Asthma Patient Alliance (NAPA) Patient Educational webinar series on Influenza and Asthma. The webinar features: -Dr. Shelly McNeil, Professor of Medicine at Dalhousie University and Vice-Chair of Immunize Canada -Rob Van Exan, Director, Immunization Policy, Sanofi Pasteur -Lynn Douglas, Medical Advisor FluMist, AstraZeneca Canada Inc.
Views: 440 AsthmaCanada